Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 29% ± 12% | |
| astrocyte | 13 studies | 31% ± 13% | |
| fibroblast | 12 studies | 24% ± 12% | |
| macrophage | 11 studies | 31% ± 15% | |
| microglial cell | 11 studies | 36% ± 11% | |
| oligodendrocyte | 11 studies | 29% ± 10% | |
| oligodendrocyte precursor cell | 10 studies | 33% ± 13% | |
| glutamatergic neuron | 9 studies | 44% ± 25% | |
| adipocyte | 9 studies | 22% ± 6% | |
| T cell | 8 studies | 20% ± 7% | |
| smooth muscle cell | 8 studies | 19% ± 3% | |
| GABAergic neuron | 7 studies | 47% ± 20% | |
| interneuron | 6 studies | 41% ± 22% | |
| naive B cell | 6 studies | 21% ± 3% | |
| myeloid cell | 6 studies | 22% ± 4% | |
| dendritic cell | 6 studies | 24% ± 4% | |
| pericyte | 6 studies | 27% ± 11% | |
| epithelial cell | 5 studies | 35% ± 15% | |
| mast cell | 5 studies | 19% ± 4% | |
| retina horizontal cell | 5 studies | 27% ± 9% | |
| endothelial cell of lymphatic vessel | 5 studies | 27% ± 11% | |
| monocyte | 5 studies | 25% ± 5% | |
| type I pneumocyte | 5 studies | 20% ± 5% | |
| type II pneumocyte | 5 studies | 20% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 18% ± 2% | |
| neuron | 4 studies | 35% ± 14% | |
| granule cell | 4 studies | 24% ± 5% | |
| cardiac muscle cell | 4 studies | 21% ± 1% | |
| ciliated cell | 4 studies | 29% ± 9% | |
| lymphocyte | 4 studies | 29% ± 11% | |
| Mueller cell | 4 studies | 29% ± 6% | |
| amacrine cell | 4 studies | 30% ± 10% | |
| retinal rod cell | 4 studies | 22% ± 4% | |
| CD8-positive, alpha-beta T cell | 4 studies | 16% ± 1% | |
| club cell | 4 studies | 22% ± 9% | |
| natural killer cell | 4 studies | 19% ± 3% | |
| regulatory T cell | 4 studies | 19% ± 2% | |
| GABAergic interneuron | 3 studies | 26% ± 5% | |
| mesothelial cell | 3 studies | 19% ± 2% | |
| GABAergic amacrine cell | 3 studies | 30% ± 10% | |
| glycinergic amacrine cell | 3 studies | 29% ± 6% | |
| B cell | 3 studies | 21% ± 5% | |
| connective tissue cell | 3 studies | 18% ± 2% | |
| ependymal cell | 3 studies | 35% ± 12% | |
| leukocyte | 3 studies | 25% ± 7% | |
| myofibroblast cell | 3 studies | 21% ± 6% | |
| alveolar macrophage | 3 studies | 26% ± 7% | |
| T follicular helper cell | 3 studies | 16% ± 1% | |
| gamma-delta T cell | 3 studies | 24% ± 3% | |
| transit amplifying cell | 3 studies | 30% ± 19% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1955.23 | 1445 / 1445 | 100% | 24.44 | 183 / 183 |
| lung | 100% | 2532.15 | 578 / 578 | 100% | 17.18 | 1155 / 1155 |
| bladder | 100% | 2437.43 | 21 / 21 | 99% | 15.45 | 500 / 504 |
| breast | 100% | 2743.44 | 459 / 459 | 99% | 19.24 | 1109 / 1118 |
| ovary | 100% | 2420.24 | 180 / 180 | 99% | 15.59 | 425 / 430 |
| uterus | 100% | 2379.11 | 170 / 170 | 99% | 19.10 | 453 / 459 |
| prostate | 100% | 2141.09 | 245 / 245 | 98% | 12.30 | 492 / 502 |
| stomach | 100% | 1405.28 | 359 / 359 | 98% | 13.04 | 280 / 286 |
| thymus | 100% | 1964.54 | 653 / 653 | 98% | 11.74 | 592 / 605 |
| intestine | 100% | 2047.73 | 966 / 966 | 98% | 12.21 | 514 / 527 |
| brain | 97% | 1718.91 | 2574 / 2642 | 100% | 15.01 | 704 / 705 |
| kidney | 100% | 1236.52 | 89 / 89 | 94% | 14.72 | 848 / 901 |
| skin | 100% | 3061.87 | 1809 / 1809 | 94% | 15.12 | 442 / 472 |
| pancreas | 95% | 749.78 | 312 / 328 | 98% | 12.82 | 175 / 178 |
| adrenal gland | 100% | 1403.43 | 258 / 258 | 85% | 6.16 | 195 / 230 |
| liver | 100% | 1164.27 | 226 / 226 | 76% | 5.28 | 310 / 406 |
| blood vessel | 100% | 2532.15 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.12 | 29 / 29 |
| spleen | 100% | 1922.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.90 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.15 | 1 / 1 |
| adipose | 100% | 2657.93 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1501.17 | 802 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 2733.41 | 891 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 1300.57 | 823 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 5.56 | 53 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | RLF |
| Protein name | Zinc finger protein Rlf (Rearranged L-myc fusion gene protein) (Zn-15-related protein) |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | Q13129 ENST00000372771.5 |